Business Context and Reporting Period
This Form 8-K Current Report, filed on April 13, 2015, covers events occurring between January 26, 2015, and March 20, 2015. The registrant, Propanc Health Group Corporation (also referred to as Propanc Biopharma, Inc.), is a Delaware corporation headquartered in Melbourne, Australia. The filing discloses the entry into multiple material definitive agreements involving the issuance of convertible notes and consulting arrangements to secure financing and services.
Key Financial Metrics and Debt Obligations
The filing details the creation of significant direct financial obligations through a series of private placements. The company issued various convertible notes with interest rates ranging from 5% to 12% per annum. Key debt instruments include:
- KBM Worldwide, Inc.: $28,000 principal, 8% interest, due October 28, 2015.
- Union Capital, LLC (Series I-IV): Multiple tranches totaling $1,000,000 in principal ($45,000 x 2, $45,000 x 2, $170,500 x 2, $150,000 x 2). Interest is 8% per annum. Terms include "Back-End" notes secured by promissory notes and significant original issue discounts (OID) on cash-funded portions.
- Carebourn Capital, L.P.: $58,000 principal, 12% interest, due July 27, 2015.
- Vis Vires Group, Inc.: $104,000 principal, 8% interest, due December 16, 2015.
- Regal Consulting, LLC: $90,000 principal, 5% interest, issued as compensation for services, due August 15, 2015.
- Circadian Group: $60,000 principal, 10% interest, issued as compensation for services, due March 11, 2017.
- Adar Bays, LLC Assignment: Replacement note of $64,736.71 principal, 8% interest, due March 4, 2016.
The filing text does not provide specific values for revenue, net profit, operating cash flow, or liquidity ratios. The primary financial activity reported is the incurrence of debt.
Material Changes and Terms
The most material change is the rapid accumulation of convertible debt obligations. Key terms across these agreements include:
- Conversion Discounts: Notes are convertible into common stock at significant discounts to market price, ranging from 40% to 55% off the lowest trading prices during specific look-back periods.
- Prepayment Penalties: Most notes include escalating prepayment penalties if the company repays early (e.g., 115% to 150% of principal and interest depending on the timing of prepayment), with no right of prepayment after 180 days for several instruments.
- Default Provisions: Default interest rates are set at 24% per annum or the highest rate permitted by law, triggering immediate due and payable status.
- Ownership Caps: Investors have agreed to limit their conversion rights to prevent ownership exceeding 4.99% or 9.99% of outstanding shares.
Outlook, Risks, and Contingencies
Risks and Contingencies:
- Dilution Risk: The deep discounts on conversion prices (up to 55%) pose a significant risk of shareholder dilution if the notes are converted.
- Liquidity Constraints: The structure of the Union Capital notes involves "Back-End" notes that are initially funded by promissory notes from the investor to the company, contingent on the investor paying off those promissory notes in cash before conversion. This creates a complex funding dependency.
- Rule 144 Compliance: Certain notes (Union Promissory Notes) may be cancelled if the company fails to meet "current public information" requirements under Rule 144.
- High Cost of Capital: The combination of high interest rates (up to 12%), original issue discounts, and prepayment penalties indicates a high cost of capital and potential financial distress.
Management Commentary: The filing states the transactions were exempt from registration under Section 4(2) of the Securities Act and Regulation D, involving accredited investors. No forward-looking guidance on revenue or product milestones is provided in this document.
Investor Verification Checklist
- Verify the total outstanding principal balance of all convertible notes and the accrued interest as of the current date.
- Confirm the company's ability to meet the "current public information" requirement under Rule 144 to prevent the cancellation of Union Capital notes.
- Assess the potential dilution impact if all notes are converted at the specified discount rates (40%-55%).
- Review the company's cash position to determine if it can service the debt or if it will be forced to convert notes, given the prepayment penalties.
- Check for any subsequent filings regarding defaults or amendments to these agreements.